TY - CONF T1 - CARDINALS: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Utreloxastat (PTC857) in Patients with Amyotrophic Lateral Sclerosis (P5-11.010) JO - Neurology UR - http://dx.doi.org/10.1212/wnl.0000000000205241 PY - 2024/04/09 AU - Katz JS AU - Vu T AU - Chio A AU - McDermott C AU - Devos D AU - Johnston M AU - Sierra R AU - Tansy A AU - Trimmer J AU - Shefner JM ED - DO - DOI: 10.1212/wnl.0000000000205241 PB - Ovid Technologies (Wolters Kluwer Health) VL - 102 IS - 17_supplement_1 Y2 - 2025/06/21 ER -